Tuesday, January 05, 2021 4:15:38 PM
"No, but when you are conducting a seminal trial, a blinded trial prevents the dangerous benefits of excessive manipulative (real-time) censoring."
yes ofcourse...that's clinical trials 101..but it's not very ethical to make terminal brain cancer patients walk around with an unpowered helmet attached to thier head for 18 hours a day. Given the promosing early data of TTFs you would have had two choices:
1) Run an unblinded trial
2) Don't run any trial and just trash it in the garbage.
I'd go for 1 every day even though it's obviously not optimal.
You seem to be saying that because there was the potential for novocure to be biased that they were and not only that that they did it on a massive scale. Yet you have no hard evidence for that at all.
"You simply can’t handle words like unreasonably “extrapolate” or “forecast.”"
KM analysis is not a forecast either. It's simply a way of making the best of lossy data.
" Why do you think Dr. Liau would state that her, and many of her colleagues do not believe Optune works? "
When did linda liau say that?
yes ofcourse...that's clinical trials 101..but it's not very ethical to make terminal brain cancer patients walk around with an unpowered helmet attached to thier head for 18 hours a day. Given the promosing early data of TTFs you would have had two choices:
1) Run an unblinded trial
2) Don't run any trial and just trash it in the garbage.
I'd go for 1 every day even though it's obviously not optimal.
You seem to be saying that because there was the potential for novocure to be biased that they were and not only that that they did it on a massive scale. Yet you have no hard evidence for that at all.
"You simply can’t handle words like unreasonably “extrapolate” or “forecast.”"
KM analysis is not a forecast either. It's simply a way of making the best of lossy data.
" Why do you think Dr. Liau would state that her, and many of her colleagues do not believe Optune works? "
When did linda liau say that?
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
